Phibro Animal Health (PAHC) CEO Daniel Bendheim Receives 11,699 RSUs

What Happened
Daniel M. Bendheim, President, CEO and Director of Phibro Animal Health Corp. (PAHC), was granted 11,699 restricted stock units (RSUs) on August 6, 2026. The reported acquisition price is $0.00, so the grant required no cash payment at grant date and is reported as an award (transaction code A).

Key Details

• Transaction date: August 6, 2026; Form 4 filed with the SEC on August 10, 2026.
• Grant: 11,699 RSUs; reported price per unit $0.00; reported value $0.
• Footnote F1: Each RSU is a contingent right to receive one share of Class A common stock upon settlement.
• Footnote F2: RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to continued employment through each vesting date.
• Shares owned after the transaction: not specified in this filing.
• Transaction type: Award/grant (not a market purchase or sale).

Context
RSUs are a form of equity compensation that convert to shares (or the economic equivalent) if and when vesting conditions are met; they are commonly used for compensation and retention. Because this is a grant rather than an open-market purchase or sale, it should be viewed as a compensation/retention event rather than a direct trading signal about the insider’s personal buying or selling intent.